630 studies found for:    Open Studies | "Liver Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE
Condition: Advanced Adult Primary Liver Cancer
Intervention: Drug: Oxaliplatin and fluorouracil
22 Recruiting 3-Tesla MRI Response to TACE in HCC (Liver Cancer)
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Stage A Adult Primary Liver Cancer (BCLC);   Stage B Adult Primary Liver Cancer (BCLC)
Interventions: Device: 3 Tesla Magnetic Resonance Imaging;   Drug: Magnevist® (Intravenous (IV) administration of MRI contrast agent)
23 Recruiting Tivozanib in Treating Patients With Liver Cancer That is Metastatic or Cannot Be Removed by Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer;   Stage C Adult Primary Liver Cancer (BCLC);   Stage D Adult Primary Liver Cancer (BCLC)
Interventions: Drug: tivozanib;   Other: pharmacological study;   Other: laboratory biomarker analysis
24 Unknown  HAI Via Interventionally Implanted Port Catheter Systems
Conditions: Colorectal Cancer;   Liver Neoplasms;   Hepatocellular Carcinoma;   Gallbladder Cancer;   Bile Duct Cancer
Intervention: Device: interventionally implanted hepatic arterial port catheter
25 Recruiting Genomic and Imaging Study for Patients Undergoing Surgery for Liver Cancer
Condition: Liver Cancer
Intervention: Drug: Fluoromethylcholine (FCH) PET/CT Imaging
26 Recruiting Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
Condition: Liver Cancer
Intervention: Device: Irreversible electroporation (IRE)
27 Recruiting Assessment of Frailty in Patients With Advanced Hepatocellular Cancers
Condition: Hepatocellular Cancer
28 Recruiting Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta
Condition: Liver Cancer
Intervention: Other: Aflatoxin
29 Unknown  Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor)
Condition: Liver Cancer
Intervention: Device: Electrosensing antibody probing system (e- Ab sensor)
30 Recruiting Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Radiation: yttrium Y 90 glass microspheres;   Other: laboratory biomarker analysis
31 Recruiting Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: sorafenib tosylate;   Other: placebo;   Other: laboratory biomarker analysis
32 Recruiting PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Stage D Adult Primary Liver Cancer (BCLC);   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: PET scan;   Procedure: CT Scan;   Procedure: hepatic artery embolization
33 Recruiting rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors
Conditions: Liver Metastases;   Primary Liver Cancers
Intervention: Biological: administration of rRp450 into the hepatic artery
34 Recruiting Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer
Condition: Hepatocellular Cancer
Interventions: Drug: Sorafenib;   Radiation: yttrium-90 radioembolization
35 Unknown  Qualitative Research for Stage 4 Liver Cancer Patients and Their Caregivers
Condition: Stage 4 Liver Cancer
Interventions: Behavioral: bulletin board or telephone depth interview (TDI);   Behavioral: interview regarding experiences and opinions as to condition and treatment
36 Unknown  Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
Condition: Liver Cancer
Interventions: Biological: recombinant interferon alfa-2b;   Drug: doxorubicin hydrochloride;   Drug: fluorouracil;   Drug: oxaliplatin;   Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Procedure: adjuvant therapy;   Procedure: biopsy;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
37 Unknown  Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer
Condition: Liver Cancer
Intervention: Radiation: stereotactic body radiation therapy
38 Recruiting Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatoma;   Liver Cancer, Adult;   Liver Cell Carcinoma, Adult
Intervention: Drug: TKM-080301
39 Not yet recruiting Integrated Imaging Strategy to Phenotype Progression of HCC Tumors During and After Chemoembolization
Conditions: Liver Cancer;   Liver Neoplasm;   Hepatocellular Carcinoma;   HCC
Intervention: Drug: [18F] FMISO
40 Unknown  Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, Stage II, or Stage III Childhood Liver Cancer
Conditions: Liver Cancer;   Ototoxicity
Interventions: Drug: cisplatin;   Drug: sodium thiosulfate;   Genetic: gene rearrangement analysis;   Genetic: microarray analysis;   Genetic: proteomic profiling;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years